1-methyl-4-phenyl-4-propionyloxypiperidine*HCl structure
|
Common Name | 1-methyl-4-phenyl-4-propionyloxypiperidine*HCl | ||
---|---|---|---|---|
CAS Number | 4968-48-3 | Molecular Weight | 283.79400 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C15H22ClNO2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 35.6 °F | |
Symbol |
GHS02, GHS07 |
Signal Word | Danger |
Name | 1-methyl-4-phenyl-4-propionyloxypiperidine*HCl |
---|---|
Synonym | More Synonyms |
Molecular Formula | C15H22ClNO2 |
---|---|
Molecular Weight | 283.79400 |
Exact Mass | 283.13400 |
PSA | 29.54000 |
LogP | 3.30060 |
Symbol |
GHS02, GHS07 |
---|---|
Signal Word | Danger |
Hazard Statements | H225-H302 + H332-H319 |
Precautionary Statements | P210-P305 + P351 + P338 |
RIDADR | UN 1648 3 / PGII |
Flash Point(F) | 35.6 °F |
Flash Point(C) | 2 °C |
Glioma cell death induced by irradiation or alkylating agent chemotherapy is independent of the intrinsic ceramide pathway.
PLoS ONE 8(5) , e63527, (2013) Resistance to genotoxic therapy is a characteristic feature of glioma cells. Acid sphingomyelinase (ASM) hydrolyzes sphingomyelin to ceramide and glucosylceramide synthase (GCS) catalyzes ceramide met... |
|
Gas-liquid chromatographic-mass spectrometric determination of 1-methyl-4-phenyl-4-propionoxypiperidine using a stable isotope-labeled analogue as an internal standard.
J. Chromatogr. A. 408 , 356-9, (1987)
|
|
Involvement of gangliosides in glucosamine-induced proliferation decrease of retinal pericytes.
Glycobiology 15(6) , 585-91, (2005) The hexosamine pathway (HP) is a biochemical hypothesis recently proposed explaining cellular alterations occurring during diabetic microvascular complications. Diabetic retinopathy is a common microv... |
3-desmethyl prodine hydrochloride |